Top Markets
Coin of the day
Mustang Bio, Inc. Mustang Bio, Inc.

Mustang Bio, Inc.

MBIO
Classement en actions #35075
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on... Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Prix de l'action
$0.594
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$4.50M
Changement (1 jour)
0.00%
Changement (1 an)
-66.44%
Pays
US
Échange Mustang Bio, Inc. (MBIO)

Catégorie

Historique des divisions d’actions pour Mustang Bio, Inc. (MBIO)
L’action Mustang Bio, Inc. (symbole : MBIO) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 16, 2026.
Une action MBIO achetée avant le Aug 16, 2026 équivaudrait aujourd’hui à 0 actions MBIO.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE